Your browser doesn't support javascript.
loading
Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS).
Fritsche, Andreas; Wagner, Robert; Heni, Martin; Kantartzis, Kostantinos; Machann, Jürgen; Schick, Fritz; Lehmann, Rainer; Peter, Andreas; Dannecker, Corinna; Fritsche, Louise; Valenta, Vera; Schick, Renate; Nawroth, Peter Paul; Kopf, Stefan; Pfeiffer, Andreas F H; Kabisch, Stefan; Dambeck, Ulrike; Stumvoll, Michael; Blüher, Matthias; Birkenfeld, Andreas L; Schwarz, Peter; Hauner, Hans; Clavel, Julia; Seißler, Jochen; Lechner, Andreas; Müssig, Karsten; Weber, Katharina; Laxy, Michael; Bornstein, Stefan; Schürmann, Annette; Roden, Michael; de Angelis, Martin Hrabe; Stefan, Norbert; Häring, Hans-Ulrich.
Afiliación
  • Fritsche A; German Center for Diabetes Research (DZD), Neuherberg, Germany andreas.fritsche@med.uni-tuebingen.de.
  • Wagner R; Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
  • Heni M; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Kantartzis K; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Machann J; Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
  • Schick F; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Lehmann R; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Peter A; Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
  • Dannecker C; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Fritsche L; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Valenta V; Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
  • Schick R; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Nawroth PP; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Kopf S; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Pfeiffer AFH; Section on Experimental Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.
  • Kabisch S; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Dambeck U; Section on Experimental Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.
  • Stumvoll M; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Blüher M; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Birkenfeld AL; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, Tübingen, Germany.
  • Schwarz P; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Hauner H; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Clavel J; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, Tübingen, Germany.
  • Seißler J; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Lechner A; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Müssig K; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Weber K; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Laxy M; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Bornstein S; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • Schürmann A; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Roden M; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • de Angelis MH; Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, Heidelberg, Germany.
  • Stefan N; Institute for Diabetes and Cancer, IDC Helmholtz Center, Munich, Germany.
  • Häring HU; Joint Heidelberg-IDC Translational Diabetes Program, Neuherberg, Germany.
Diabetes ; 70(12): 2785-2795, 2021 12.
Article en En | MEDLINE | ID: mdl-34531293
ABSTRACT
Lifestyle intervention (LI) can prevent type 2 diabetes, but response to LI varies depending on risk subphenotypes. We tested whether individuals with prediabetes with low risk (LR) benefit from conventional LI and individuals with high risk (HR) benefit from an intensification of LI in a multicenter randomized controlled intervention over 12 months with 2 years' follow-up. A total of 1,105 individuals with prediabetes based on American Diabetes Association glucose criteria were stratified into an HR or LR phenotype based on previously described thresholds of insulin secretion, insulin sensitivity, and liver fat content. LR individuals were randomly assigned to conventional LI according to the Diabetes Prevention Program (DPP) protocol or control (11) and HR individuals to conventional or intensified LI with doubling of required exercise (11). A total of 908 (82%) participants completed the study. In HR individuals, the difference between conventional and intensified LI in postchallenge glucose change was -0.29 mmol/L [95% CI -0.54; -0.04], P = 0.025. Liver fat (-1.34 percentage points [95% CI -2.17; -0.50], P = 0.002) and cardiovascular risk (-1.82 percentage points [95% CI -3.13; -0.50], P = 0.007) underwent larger reductions with intensified than with conventional LI. During a follow-up of 3 years, intensified compared with conventional LI had a higher probability of normalizing glucose tolerance (P = 0.008). In conclusion, it is possible in HR individuals with prediabetes to improve glycemic and cardiometabolic outcomes by intensification of LI. Individualized, risk phenotype-based LI may be beneficial for the prevention of diabetes.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estado Prediabético / Diabetes Mellitus Tipo 2 / Estilo de Vida Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estado Prediabético / Diabetes Mellitus Tipo 2 / Estilo de Vida Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article